BRIEF-Eleven Biotherapeutics reports Q3 2016 financial results
November 14, 2016 at 08:05 AM EST
* Believe that cash, cash equivalents as of september 30, 2016 will enable co to fund operating expenses into 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.